The PGK1 gene gives cells instructions for an enzyme that helps turn sugar into usable energy, especially in muscles, red blood cells, and the brain. This gene helps your body keep energy flowing during exercise and other everyday demands. If the gene does not work properly, people may develop PGK1 deficiency, which can lead to muscle weakness or cramps, breakdown of red blood cells, and sometimes brain related symptoms such as developmental delay or seizures. Because the PGK1 gene is on the X chromosome, effects often differ between males and females.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for making proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to explore this topic in more detail, you can learn more in the LearnHub.
Overview
PGK1Gene function
What if the gene works
The PGK1 gene helps cells make energy from sugar. Its protein is part of glycolysis, a step by step process that produces ATP, the main fuel cells use every day.
Risk
What if the gene does not work
Variants in the PGK1 gene can cause PGK1 deficiency, leading to anemia from red blood cell breakdown, exercise related muscle problems, and sometimes brain or nerve problems. Mild and severe variants can affect which features appear and when they begin.
Treatment
What does that mean for your treatment
No PGK1-specific treatment or drug selection approach is currently established for pathogenic variants in the PGK1 gene. The PGK1 gene is being studied as a metabolic marker and possible drug target in some cancers, but this has not led to routine treatment decisions for inherited PGK1-related conditions.
Conditions associated with PGK1
Gene function
What if the gene works
Inside many cells, the PGK1 gene helps turn sugar into usable energy. It works in glycolysis, a step by step process that lets cells make ATP, the small molecule they use for everyday tasks. Understanding how the PGK1 gene helps cells make energy makes its role in the body easier to picture.
The PGK1 gene helps cells harvest energy from glucose during glycolysis. It carries out one of the key steps where ATP is made directly.
Its protein moves a phosphate group onto ADP (a form that cells can turn into ATP). This gives cells a ready supply of energy for routine tasks like transport, signaling, and movement.
This step changes the sugar molecule into the next form needed for the rest of glycolysis. By keeping that sequence moving, the PGK1 gene supports steady day to day cell activity.
What is a variant?
Within a gene, a genetic variant is a small change in the DNA sequence. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PGK1 gene can change the shape of the PGK1 protein, reduce its stability, lower enzyme activity, or stop the cell from making a full-length protein. This helps explain how PGK1 gene variants affect energy production in cells: milder changes may leave some activity, while more disruptive variants often cause a larger loss. When a PGK1-related condition is present, the amount of activity left can influence which features appear and how early they begin.
How variants are linked to conditions
Variants in the PGK1 gene cause phosphoglycerate kinase deficiency, a rare X-linked condition. PGK1 deficiency symptoms can include ongoing anemia, muscle pain or weakness with exercise, and in some people developmental or neurologic features such as seizures. Symptoms vary widely, even within the same family.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely found across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For PGK1, risk is mainly shaped by whether a disease-causing change in the gene is present and whether someone is male or female, because this gene is on the X chromosome. In people already living with a PGK1-related condition, hard exercise, infections, and other body stress can sometimes trigger symptoms, but there is not enough evidence to say lifestyle changes lower the underlying genetic risk.
Inheritance of PGK1 variants
PGK1-related conditions usually follow an X-linked inheritance pattern, which is the key point in understanding how PGK1 gene variants are inherited. Because the PGK1 gene is on the X chromosome, a mother carrying a disease-causing variant can pass it to both sons and daughters, while a father passes his X chromosome only to his daughters. Males who inherit the variant are more likely to be affected because they have one X chromosome. Females who inherit the variant may have milder features or no symptoms, although this can vary.
What does my PGK1 result mean for my family?
A change in the PGK1 gene usually follows an X-linked pattern, so it can matter for relatives on the mother’s side of the family. Brothers, sisters, and children may also carry the change or be affected, with males often more likely to have clear symptoms and females sometimes having milder or no symptoms. Family implications can vary from one family to another, depending on who carries the gene change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PGK1 variants usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA in the PGK1 gene to look for variants that may help explain symptoms or show whether a change runs in a family. Results may identify a variant known to cause disease, a harmless variant, or an unclear finding.
When should I consider getting a genetic test?
Consider testing for the PGK1 gene if there is a family history of PGK1-related illness, or if someone has unexplained long-term anemia, repeated muscle breakdown after exercise, or both. Testing can help confirm whether a change in PGK1 is the cause, especially in boys and men because this gene is on the X chromosome.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Lifestyle, environment, age, and medical history, among other factors, also shape how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best interpreted together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, moved through the body, or reaches its target, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect a person’s response to medicines. It focuses on links between genes and medications to clarify why the same treatment may not work in the same way for everyone. With many drugs, genes can influence either how powerfully a medicine works or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More detail on this subject is available in the LearnHub.
Drugs influenced by the PGK1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about side effects, treatment response, or new symptoms are best discussed with your doctor. Research on PGK1 has looked at whether its activity in some tumors is linked with response to certain cancer treatments, but this has not become routine medication guidance.
History
The history of the PGK1 gene began in clinical medicine, when doctors recognized a rare inherited condition in boys and men with muscle symptoms and episodes of anemia in the late 1960s. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became known as PGK1 deficiency. As genetic methods improved in the 1980s and 1990s, researchers mapped the PGK1 gene to the X chromosome and identified the first disease causing variants. These findings helped explain why symptoms could differ even within the same family. Over time, descriptions became more precise. Today, the PGK1 gene is mainly known in specialist genetics and metabolic medicine rather than through broad public awareness.